Kerendia 20 mg/1
finerenone · TABLET, FILM COATED · Bayer HealthCare Pharmaceuticals Inc.
Kerendia (finerenone) is an oral tablet used to treat chronic kidney disease in patients with type 2 diabetes. It works by blocking mineralocorticoid receptors, which helps protect the kidneys from further damage.
Key Facts
- Brand Name
- Kerendia
- Generic Name
- finerenone
- NDC Code (Product)
50419-541- Manufacturer
- Bayer HealthCare Pharmaceuticals Inc.
- Strength
- 20 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA215341
- Drug Class
- Nonsteroidal Mineralocorticoid-Receptor Antagonist [EPC]
- Marketing Start
- 07/09/2021
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Frequently Asked Questions
What is Kerendia used for?
Kerendia (finerenone) is an oral tablet used to treat chronic kidney disease in patients with type 2 diabetes. It works by blocking mineralocorticoid receptors, which helps protect the kidneys from further damage.
Is Kerendia a controlled substance?
Kerendia is not classified as a controlled substance by the DEA.
What is the generic name for Kerendia?
The generic name for Kerendia is finerenone. There are no other listed brand versions of finerenone.
What is the NDC code for Kerendia 20 mg/1?
The NDC (National Drug Code) for Kerendia 20 mg/1 is 50419-541, listed by Bayer HealthCare Pharmaceuticals Inc..
Other Kerendia Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)